Recent developments in the treatment of atopic eczema

Journal of the American Academy of Dermatology

Volumn 36, Issue 6 I, 1997, Pages 983-994

  Brehler, R ^a   Hildebrand, A ^a   Luger, T A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALPHA INTERFERON; CROMOGLYCATE DISODIUM; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; GAMMA LINOLENIC ACID; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; KETOTIFEN; PHOSPHODIESTERASE INHIBITOR; PLACEBO; TACROLIMUS; THYMOPENTIN;

ANTIGEN ANTIBODY COMPLEX; ATOPIC DERMATITIS; BLOOD TOXICITY; CHINESE HERB; CLINICAL TRIAL; DIET SUPPLEMENTATION; FEVER; HUMAN; HYPERTENSION; IMMUNOTHERAPY; NAUSEA; NEPHROTOXICITY; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; SKIN MANIFESTATION; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

EID: 0030918150     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(97)80284-8     Document Type: Article

References (154)

1. Przybilla B. Eberlein Konig B. Rueff F. Practical management of atopic eczema Lancet 343 1994 1342 1346
2. Luger T.A. Schwarz T. Effects of UV-light on cytokines and neuroendocrine hormones Krutmann J. Elmets C. Photoimmunology 1995 Blackwell Oxford 55 76
3. Cruz P.D. Jr. UVB-induced unresponsiveness and tolerance induction: a central role for epidermal Langerhans cells Krutmann J. Elmets C.A. Photoimmunology 1995 Blackwell Oxford 90 98
4. Krutmann J. Schlipf E. High-dose-UVA1 phototherapy: a novel and highly effective approach for the treatment of acute exacerbation of atopic dermatitis Acta Derm Venereol Suppl (Stockh) 176 1992 120 122
5. Picot E. Meunier L. Picot Debeze M.C. Treatment of psoriasis with a 311-mm UVB lamp Br J Dermatol 127 1992 509 512
6. Storbeck K. Holzle E. Schurer N. Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis J Am Acad Dermatol 28 1993 227 231
7. George S.A. Bilsland D.J. Johnson B.E. Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis Br J Dermatol 128 1993 49 56
8. Falk E.S. UV-light therapies in atopic dermatitis Photodermatology 2 1985 241 246
9. Midelfart K. Stenvold S.E. Volden G. Combined UVB and UVA phototherapy of atopic eczema Dermatologica 171 1985 95 98
10. Jekler J. Larko O. Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study J Am Acad Dermatol 22 1990 49 53
11. Jekler J. Larko O. UVA solarium versus UVB phototherapy of atopic dermatitis: a paired-comparison study Br J Dermatol 125 1991 569 572
12. Atherton D.J. Carabott F. Glover M.T. The role of psoralen photochemotherapy (PUVA) in the treatment of severe atopic eczema in adolescents Br J Dermatol 118 1988 791 795
13. Calzavara Pinton P.G. Ortel B. Honigsmann H. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis Dermatology 189 1994 256 259
14. Zimmermann J. Utermann S. Photo-brine therapy in patients with psoriasis and neurodermatitis atopica Hautarzt 45 1994 849 853
15. Streit V. Wiedow O. Christophers E. Innovative balneo-therapy with reduced bath volume: foil baths Hautarzt 45 1994 140 144
16. Prinz B. Nachbar F. Plewig G. Treatment of severe atopic dermatitis with extracorporeal photopheresis Arch Dermatol Res 287 1994 48 52
17. Krutmann J. Czech W. Diepgen T. High-dose-UVAI therapy in the treatment of patients with atopic dermatitis J Am Acad Dermatol 26 1992 225 230
18. Czech W. Krutmann J. Schopf E. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis Br J Dermatol 126 1992 351 355
19. Kowalzick L. Kleinheinz A. Weichenthal M. Low dose versus medium dose UV-A1 treatment in severe atopic eczema Acta Derm Venereol (Stockh) 75 1995 43 45
20. Meffert H. Sönnichsen N. Herzog M. UVA-1-Kaltlichttherapie des akut exazerbierten, schweren atopischen Ekzems Dermatol Monatsschr 178 1992 291 296
21. Ely H. Recent developments in dermatologic uses of cyclosporine and amelioration of renal toxicity with pentoxifylline Curr Opin Immunol 5 1993 223 230
22. Camp R.D.R. Reitamo S. Friedmann P.S. Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop. April 1993 Br J Dermatol 129 1993 217 220
23. Munro C.S. Levell N.J. Shuster S. Maintenance treatment with cyclosporin in atopic eczema Br J Dermatol 130 1994 376 380
24. Sepp N. Fritsch P.O. Can cyclosporin A induce permanent remission of atopic dermatitis? Br J Dermatol 128 1993 213 216
25. Freeman D. Grant D. Levy G. Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients Ther Drug Monit 17 1995 213 216
26. Niese D. A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months—The International Sandimmun Neoral Study Group Transplant Proc 27 1995 1849 1856
27. Andersen W.K. Feingold D.S. Adverse drug interactions clinically important for the dermatologist Arch Dermatol 131 1995 468 473
28. Cockburn I.T. Krupp P. An appraisal of drug interactions with Sandimmun Transplant Proc 21 1989 3845 3850
29. Mihatsch M.J. Wolff K. Consensus conference on cyclosporin A for psoriasis, February 1992 Br J Dermatol 126 1992 621 623
30. Lembo G. Balato N. Patruno C. Influence of topically applied cyclosporin A in various vehicles on patch test reactions Contact Dermatitis 26 1992 56 57
31. De Rie M.A. Meinardi M.M. Bos J.D. Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis Acta Derm Venereol (Stockh) 71 1991 452 454
32. Surber C. Itin P. Buchner S. Clinical controversy on the effect of topical cyclosporin: What is the target site? Dermatology 185 1992 242 245
33. Bos J.D. Witkamp L. Zonnevald I.M. Systemic tacrolimus (FK 506) is effective in the treatment of psoriasis in a double-blind, placebo-controlled study Arch Dermatol 132 1996 419 423
34. Meingassner J.G. Stutz A. Immunosuppressive macrolides of the type FK506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 98 1992 851 855
35. [letter] Lauerma A.I. Maibach H.I. Granlund H. Inhibition of contact allergy reactions by topical FK506 Lancet 340 1992 556
36. [letter] Nakagawa H. Etch T. Ishibashi Y. Tacrolimus ointment for atopic dermatitis Lancet 344 1994 883
37. Aoyama H. Tabata N. Tanaka M. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment Br J Dermatol 133 1995 494 496
38. [abstract] Wolff K. Meingasser J.G. Fedinger D. Clearing of psoriasis by a novel macrolide Skin Pharmacol 8 1995 69
39. Luger T.A. Trautinger F. Schwarz T. Cytokines: therapeutic aspects for skin diseases Luger T.A. Schwarz T. Epidermal growth factors and cytokines 1993 Marcel Dekker New York 453 474
40. Friedman R.M. Interferons Oppenheim J.J. Shevach E.M. Immunophysiology: the role of cells and cytokines in immunity and inflammation 1990 Oxford University Press New York 194 209
41. Cooper K.D. Atopic dermatitis: recent trends in pathogenesis and therapy J Invest Dermatol 102 1994 128 137
42. Takagi M. Koike K. Nakahata T. Antiproliferative effect of IFN-gamma on proliferation of mouse connective tissue-type mast cells J Immunol 145 1990 1880 1884
43. 2 Proc Natl Acad Sci U S A 85 1988 6880 6884
44. Swieter M. Ghali W.A. Rimmer C. Interferon-alpha/beta inhibits IgE-dependent histamine release from rat mast cells Immunology 66 1989 606 610
45. Schandene L. Del Prete G.F. Cogan E. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells J Clin Invest 97 1996 309 315
46. Hanifin J.M. Schneider L.C. Leung D.Y. Recombinant interferon gamma therapy for atopic dermatitis J Am Acad Dermatol 28 1993 189 197
47. Luger T.A. Cytokine treatment of mast cell mediated skin diseases Exp Dermatol 4 1995 277 280
48. Bellanti J.A. Pung Y. Use of interferons in allergic disease and its possible use in food allergy Johansson S.G.O. Progress in allergy and clinical immunology vol 3 1995 Hofgrefe & Huber Stockholm 275 282
49. Czarnetzki B.M. Algermissen B. Jeep S. Interferon treatment of patients with chronic urticaria and mastocytosis J Am Acad Dermatol 30 1994 500 501
50. Sunderkötter C. Luger T. Kolde G. Severe hypertriglyceridaemia and interferon-alpha Lancet 342 1993 1111 1112
51. Asnis L.A. Gaspari A.A. Cutaneous reactions to recombinant cytokine therapy J Am Acad Dermatol 33 1995 393 410
52. Spiegelberg H.L. Falkoff R.J. O'Connor R.D. Interleukin-2 inhibits the interleukin-4-induced human IgE and IgG4 secretion in vivo Clin Exp Immunol 84 1991 400 405
53. Hsieh K.H. Chou C.C. Huang S.F. Interleukin 2 therapy in severe atopic dermatitis J Clin Immunol 11 1991 22 28
54. Romagnani S. T cells, cytokines, and IgE regulation in allergic disease Johansson S.G.O. Progress in allergy and clinical immunology vol 3 1995 Hofgrefe and Huber Stockholm 5 12
55. Romani N. Heufler C. Koch F. Cytokines and Langerhans cells Luger T.A. Schwarz T. Epidermal growth factors and cytokines 1993 Marcel Dekker New York 345 364
56. Kapp A. Kirnbauer R. Luger T.A. Altered production of immunomodulating cytokines in patients with atopic dermatitis Acta Derm Venereol Suppl (Stockh) 144 1989 97 99
57. Bochner B.S. Charlesworth E.N. Lichtenstein L.M. Interleukin-1 is released at sites of human cutaneous allergic reactions J Allergy Clin Immunol 86 1990 830 839
58. Sim T.C. Alam R. Hilsmeier K.A. Detection of inflammatory cytokines in nasal secretions of allergic subjects following antigen challenge J Allergy Clin Immunol 89 1992 287 294
59. Mullarkey M.F. Leiferman K.M. Peters M.S. Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor J Immunol 152 1994 2033 2041
60. Goldstein G. Scheid M.P. Boyse E.A. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin Science 204 1979 1309 1310
61. Leung D.Y. Hirsch R.L. Schneider L. Thymopentin therapy reduces the clinical severity of atopic dermatitis J Allergy Clin Immunol 85 1990 927 933
62. Kang K. Cooper K.D. Hanifin J.M. Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis J Am Acad Dermatol 8 1983 372 377
63. Stiller M.J. Shupack J.L. Kenny C. A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis J Am Acad Dermatol 30 1994 597 602
64. Bruijnzeel P.L. Kuijper P.H. Kapp A. The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis Clin Exp Allergy 23 1993 97 109
65. Bieber T. Fc epsilon RI on human Langerhans cells: a receptor in search of new functions Immunol Today 15 1994 52 53
66. Ring J. Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins Br J Dermatol 107 1982 597 602
67. Nish W.A. Charlesworth E.N. Davis T.L. The effect of immunotherapy on the cutaneous late phase response to antigen J Allergy Clin Immunol 93 1994 484 493
68. Di Prisco de Fuenmayor M.C. Champion R.H. Specific hyposensitization in atopic dermatitis Br J Dermatol 101 1979 697 700
69. Glover T. Atherton D.J. A double-blind controlled trial of hyposensitization to Dennatophagoides pteronyssinus in children with atopic eczema Clin Exp Allergy 22 1992 440 446
70. Heijer A. Hyposensitization with aeroallergens in atopic eczema Allerg J 1 1993 3 7
71. Saint-Remy J.M.R. Machiels J.J. Allergen-antibody complexes in the treatment of Dennatophagoides pteronyssinus hypersensitivity diseases Clin Exp Allergy 24 1994 1091 1094
72. Jacquemin M.G. Machiels J.J. Lebrun P.M. Successful treatment of atopic dermatitis with complexes of allergen and specific antibodies Lancet 335 1990 1468 1469
73. Machiels J.J. Somville M.A. Lebrun P.M. Allergic bronchial asthma due to Dennatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes J Clin Invest 85 1990 1024 1035
74. Leroy B. Lachapelle J.M. Jacquemin M.G. Immuno-therapy of atopic dermatitis by injections of antigen-antibody complexes Dermatology 186 1993 276 277
75. Leroy B.P. Boden G. Lachapelle J.M. A novel therapy for atopic dermatitis with aIiergen-antibody complexes: a double-blind, placebo-controlled study J Am Acad Dermatol 28 1993 232 239
76. Leroy B.P. Lachapelle J.M. Somville M.M. Injection of allergen-antibody complexes is an effective treatment of atopic dermatitis Dermatologica 182 1991 98 106
77. Norman P.S. Immunotherapy for nasal allergy J Allergy Clin Immunol 81 1988 992 996
78. O'Hehir R.E. Yssel H. Venn S. Clonal analysis of differential lymphokine production in peptide and super-antigen induced T cell anergy Int Immunol 3 1991 819 826
79. Zurawski G. de Vries J.E. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells Immunol Today 15 1994 19 26
80. de Vries J.E. Gauchat J.F. Aversa G.G. Regulation of IgE synthesis by cytokines Curr Opin Immunol 3 1991 851 858
81. Weaver C.T. Unanue E.R. The costimulatory function of antigen presenting cells Immunol Today 11 1990 49 55
82. Jenkins M.K. Miller R.A. Memory and anergy: challenges to traditional models of T-lymphocyte differentiation FASEB J 6 1992 2428 2433
83. Cocks B.G. Chang C.C. Carballido J.M. A novel receptor involved in T-cell activation Nature 376 1995 260 263
84. Yssel H. Fasler S. Lamb J. Induction of non-responsiveness in human allergen-specific type 2 T helper cells Curr Opin Immunol 6 1994 847 852
85. LaSalle J.M. Tolentino P.J. Freeman G.J. Early signaling defects in human T cells anergized by T cell presentation of autoantigen J Exp Med 176 1992 177 186
86. Scheiner O. Kraft D. Basic and practical aspects of recombinant allergens Allergy 50 1995 384 391
87. Ebner C. Szepfalusi Z. Ferreira F. Identification of multiple T cell epitopes on Bet v I , the major birch pollen allergen, using specific T cell clones and overlapping peptides J Immunol 150 1993 1047 1054
88. Spiegelberg H.L. Beck L. Stevenson D.D. Recognition of T cell epitopes and lymphokine secretion by rye grass allergen Lolium perenne I-specific human T cell clones J Immunol 152 1994 4706 4711
89. Verhoef A. Higgins J.A. Thorpe C.J. Clonal analysis of the atopic immune response to the group 2 allergen of Fermatophagoides spp.: identification of HLA-DR and -DQ restricted T cell epitopes Int Immunol 5 1993 1589 1597
90. Yssel H. Johnson K.E. Schneider P.V. T cell activation-inducing epitopes of the house dust mite allergen Der p I : proliferation and lymphokine production patterns by Der p I -specific CD4+ T cell clones J Immunol 148 1992 738 745
91. Briner T.J. Kuo M.C. Keating K.M. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I Proc Natl Acad Sci U S A 90 1993 7608 7612
92. Hoyne G.F. O'Hehir R.E. Wraith D.C. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice J Exp Med 178 1993 1783 1788
93. Norman P.S. Lichtenstein L.M. Initial clinical experiences with allergen peptides Johansson S.G.O. Progress in allergy and clinical immunology vol 3 1995 Hofgrefe & Huber Stockholm 234 236
94. 2 in 2 patients with bee venom allergy. In Ring J, Berendt H, editors. New trends in allergy IV. Berlin: Springer. In press.
95. Ball T. Vrtala S. Sperr W.R. Isolation of an immunodominant IgE hapten from an epitope expression cDNA library: dissection of the allergic effector reaction J Biol Chem 269 1994 28323 28328
96. Stadler B.M. Stampfli M.R. Miescher S. Cloning of human anti-IgE autoantibodies and their role in the regulation of IgE synthesis Int Arch Allergy Immunol 107 1995 48 50
97. Carballido J.M. Aversa G. Schols D. Inhibition of human IgE synthesis in vitro and in SCID-hu mice by an interleukin-4 receptor antagonist Int Arch Allergy Immunol 107 1995 304 307
98. Manetti R. Parronchi P. Giudizi M.G. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells J Exp Med 177 1993 1199 1204
99. Renz H. Enssle K. Lauffer L. Inhibition of allergen-induced IgE and IgGI production by soluble IL-4 receptor Int Arch Allergy Immunol 106 1995 46 54
100. Kung T.T. Stelts D.M. Zurcher J.A. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody Am J Respir Cell Mol Biol 13 1995 360 365
101. Kruse N. Tony H.P. Sebald W. Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement EMBO J 11 1992 3237 3244
102. Latchman Y. Whittle B. Rustin M. The efficacy of traditional Chinese herbal therapy in atopic eczema Int Arch Allergy Immunol 104 1994 222 226
103. Latchman Y. Banerjee P. Poulter L.W. Association of immunological changes with clinical efficacy in atopic eczema patients treated with traditional Chinese herbal therapy (Zemaphyte) Int Arch Allergy Immunol 109 1996 243 249
104. Sheehan M.P. Rustin M.H. Atherton D.J. Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis Lancet 340 1992 13 17
105. Bamford J.T. Gibson R.W. Renier C.M. Atopic eczema unresponsive to evening primrose oil (linoleic and gamma-linolenic acids) J Am Acad Dermatol 13 1985 959 965
106. Kragballe K. Fisher G.J. Voorhees J.J. Eicosanoids in inflammatory and immunology skin disorders Bos J.D. Skin immune system 1990 CRC Press Boca Raton, FL 243 255
107. Ruzicka T. Simmet T. Peskar B.A. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis J Invest Dermatol 86 1986 105 108
108. Fogh K. Herlin T. Kragballe K. Eicosanoids in skin of patients with atopic dermatitis: prostaglandin E2 and leukotriene B4 are present in biologically active concentrations J Allergy Clin Immunol 83 1989 450 455
109. Businco L. Ioppi M. Morse N.L. Breast milk from mothers of children with newly developed atopic eczema has low levels of long chain polyunsaturated fatty acids J Allergy Clin Immunol 91 1993 1134 1139
110. Goodwin J.S. Messner R.P. Peake G.T. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro: changes with mitogen dose and preincubation J Clin Invest 62 1978 753 760
111. Santoli D. Phillips P.D. Colt T.L. Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids: evidence for a PGE-independent mechanism of inhibition by the fatty acids J Clin Invest 85 1990 424 432
112. Soyland E. Nenseter M.S. Braathen L. Very long chain n-3 and n-6 polyunsaturated fatty acids inhibit proliferation of human T-lymphocytes in vitro Eur J Clin Invest 23 1993 112 121
113. Soyland E. Lea T. Sandstad B. Dietary supplementation with very long-chain n-3 fatty acids in man decreases expression of the interleukin-2 receptor (CD25) on mitogen-stimulated lymphocytes from patients with inflammatory skin diseases Eur J Clin Invest 24 1994 236 242
114. Berth Jones J. Graham Brown R.A. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis Lancet 341 1993 1557 1560
115. Soyland E. Funk J. Rajka G. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis: a double-blind, multicentre study Br J Dermatol 130 1994 757 764
116. Wright S. Burton J.L. Oral evening-primrose-seed oil improves atopic eczema Lancet 2 1982 1120 1122
117. Grewe S.R. Chan S.C. Hanifin J.M. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness J Allergy Clin Immunol 70 1982 452 457
118. Berth Jones J. Graham Brown R.A. Failure of papaverine to reduce pruritus in atopic dermatitis: a double-blind, placebo-controlled cross-over study Br J Dermatol 122 1990 553 557
119. Hanifin J.M. Dohi Memorial Lecture: new therapeutic rewards from clinical research in atopic dermatitis J Dermatol 21 1994 705 708
120. Kimata H. Igarashi M. Topical cromolyn (disodium cromoglycate) solution in the treatment of young children with atopic dermatitis Clin Exp Allergy 20 1990 281 283
121. Burek-Kozlowska A. Morek A. Hunziker T. Topical immunoglobulin G in atopic dermatitis Int Arch Allergy Immunol 104 1994 104 106
122. van Joost T. Stolz E. Heule F. Efficacy of low-dose cyclosporine in severe atopic skin disease Arch Dermatol 123 1987 166 167
123. Logan R.A. Camp R.D. Severe atopic eczema: response to oral cyclosporin A J R Soc Med 81 1988 417 418
124. Motley R.J. Whittaker J.A. Holt P.J. Resolution of atopic dermatitis in a patient treated with cyclosporin Clin Exp Dermatol 14 1989 243 244
125. Taylor R.S. Cooper K.D. Headington J.T. Cyclosporine therapy for severe atopic dermatitis J Am Acad Dermatol 21 1989 580 583
126. Gold M.H. Picascia D.D. Roenigk H.H.J. Treatment-resistant atopic dermatitis controlled with cyclosporin A Int J Dermatol 28 1989 481 482
127. Wahlgren C.F. Scheynius A. Hagermark O. Antipruritic effect of oral cyclosporin A in atopic dermatitis Acta Derm Venereol (Stockh) 70 1990 323 329
128. Ross J.S. Camp R.D.R. Cyclosporin A in atopic dermatitis: 5 years on Br J Dermatol 127 1992 32 36
129. Munro C.S. Higgins E.M. Marks J.M. Cyclosporin A in atopic dermatitis: therapeutic response is dissociated fromeffects on allergic reactions Br J Dermatol 124 1991 43 48
130. Sowden J.M. Berth Jones J. Ross J.S. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis Lancet 338 1991 137 140
131. Korstanje M.J. van de Staak W.J. Cyclosporin maintenance therapy for severe atopic dermatitis Acta Derm Venereol (Stockh) 71 1991 356 357
132. van Joost T. Kozel M.M. Tank B. Cyclosporine in atopic dermatitis: modulation in the expression of immunologic markers in lesional skin J Am Acad Dermatol 27 1992 922 928
133. Munro C. Levell N. Friedmann P. Low dose intermittent cyclosporin maintains remission in atopic dermatitis Br J Dermatol 127 1992 13 17
134. Ross I.S. Camp R.D.R. Cyclosporin in atopic dermatitis Br J Dermatol 122 1990 41 45
135. Salek M.S. Finlay A.Y. Luscombe D.K. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial Br J Dermatol 129 1993 422 430
136. MacKie R.M. Interferon-alpha for atopic dermatitis Lancet 335 1990 1282 1283
137. Thestrup Pedersen K. Nielsen B.W. Larsen C.G. Interferon-alpha treatment of atopic dermatitis patients with increased serum IgE Shroot B. Schaefer H. Immunological and pharmacological aspects of atopic and contact eczema 1991 Karger Basel 210 214
138. Torrelo A. Harto A. Sendagorta E. Interferon-alpha therapy in atopic dermatitis Acta Derm Venereol (Stockh) 72 1992 370 372
139. Jullien D. Nicolas J.F. Frappaz A. Alpha interferon treatment in atopic dermatitis Acta Derm Venereol (Stockh) 73 1993 130 132
140. Paukkonen K. Fraki J. Horsmanheimo M. Interferon-alpha treatment decreases the number of blood eosinophils in patients with severe atopic dermatitis Acta Derm Venereol (Stockh) 73 1993 141 142
141. Gruschwitz M.S. Peters K.P. Heese A. Effects of interferon-alpha-2b on the clinical course, inflammatory skin infiltrates and peripheral blood lymphocytes in patients with severe atopic eczema Int Arch Allergy Immunol 101 1993 20 30
142. Kropp J.D. Algermissen B. Buck S. Pilot study of the effect of interferon-alpha on atopic eczema Hautarzt 45 1994 225 227
143. Nielsen B.W. Reimert C.M. Hammer R. Interferon therapy for atopic dermatitis reduces basophil histamine release, but does not reduce serum IgE or eosinophific proteins Allergy 49 1994 120 128
144. Michils A. Farber C.M. Van Vooren J.P. Sustained benefit of interferon-alpha therapy and oral hyposensitization in severe atopic dermatitis Br J Dermatol 130 1994 134 135
145. Kimata H. Akiyama Y. Kubota M. Interferon-alpha treatment for severe atopic dermatitis Allergy 50 1995 837 840
146. Boguniewicz M. Jaffe H.S. Izu A. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels Am J Med 88 1990 365 370
147. [letter] Reinhold U. Wehrmann W. Kukel S. Recombinant interferon-gamma in severe atopic dermatitis Lancet 335 1990 1282
148. [letter] Souillet G. Rousset F. de Vries J.E. Alpha-interferon treatment of patients with hyper-IgE syndrome Lancet 2 1990 1384
149. Reinhold U. Kukel S. Brzoska J. Kreysel H.W. Systemic interferon gamma treatment in severe atopic dermatitis J Am Acad Dermatol 29 1993 58 63
150. Horneff G. Dirksen U. Wahn V. Interferon-gamma for treatment of severe atopic eczema in two children Clin Invest 72 1994 400 403
151. Nishioka K. Matsunaga T. Katayama I. Gamma-interferon therapy for severe cases of atopic dermatitis of the adult type J Dermatol 22 1995 181 185
152. Musial J. Milewski M. Undas A. Human recombinant interferon gamma in the treatment of atopic dermatitis Pol Arch Med Wewn 92 1994 499 506
153. Pt B Steinmann G.G. Roseukaimer F. Leitz G. Clinical experiences with interferon-alpha and interferon-gamma Int Rev Exp Pathol 34 1993 193 207
154. Stadler R. Ruszczak Z. Interferons: new additions and indications for use Dermatol Clin 11 1993 187 199